Risks of ‘Miracle’ Weight-Loss Jabs
A landmark study involving over two million patients has highlighted serious risks linked to weight-loss drugs like Ozempic, Wegovy, and Mounjaro. While the benefits are significant, researchers warn the side effects can be “quite severe” and “need to be recognised.”
1. Hospitalisations Rising: Over 120 patients were hospitalised in the past month due to reactions.
2. Study Details: Washington University analysed data from 215,000 users of these drugs, comparing them to two million on traditional diabetes medication.
The findings underscore the importance of balancing benefits with potential risks when using these treatments.
